Clinical trial
Efficacy of Docetaxel (J 15) and Celecoxib in Metastatic Prostate Cancer
NCT00213694 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Docetaxel (J 15) and Celecoxib in Metastatic Prostate Cancer
- Lead sponsor
- University Hospital, Rouen
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2003
- Completion date
- June 30, 2006
- Enrollment
- 52
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic prostate cancer